Idrofos 150 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Ibandronic Acid (150mg)
Overview Idrofos 150 Tablet
Osteoclast activity inhibition is the mechanism by which Fosmax 150mg tablets combat and prevent postmenopausal osteoporosis. This medication strengthens bones, reducing fracture risk in postmenopausal women with osteoporosis. Optimal absorption occurs when taken on an empty stomach, consistently as directed by your physician. Maintain consistent dosing, even after symptom improvement, as full efficacy may take several days. Fosmax 150mg tablets are part of a comprehensive treatment strategy that may include dietary adjustments and supplementation with calcium and vitamins. Common, typically mild and transient, side effects encompass headache, elevated cholesterol, dizziness, upper respiratory and urinary tract infections, musculoskeletal pain, dyspepsia, heartburn, and diarrhea. Persistent symptoms warrant medical consultation. Serious, potentially life-threatening renal complications, especially in dehydrated patients, those on diuretics, or with pre-existing renal impairment, may occur. Hypocalcemia and orofacial pain also require prompt medical attention. Breastfeeding contraindicates Fosmax 150mg use. Prior to initiating treatment, disclose any renal dysfunction, hypocalcemia, or concurrent medications, particularly those for severe infections, cancer, or osteoporosis, to your physician. Regular monitoring of renal function and mineral levels may be necessary. Smoking cessation is advisable due to its negative impact on bone density; excessive alcohol consumption should also be avoided.
Primary Ingredients of Idrofos 150 Tablet
There is no text provided to rephrase.
Uses of Idrofos 150 Tablet
Managing and mitigating postmenopausal osteoporosis.
Major Benefits of Idrofos 150 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Idrofos 150 Tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
Common Side effects of Idrofos 150 Tablet:
- Headache
- Musculoskeletal (bone, muscle or joint) pain
- Heartburn
- Diarrhea
- Indigestion
- Dizziness
- Hypercholesterolemia (high cholesterol)
- Upper respiratory tract infection
- Urinary tract infection
How to use Idrofos 150 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Idrofos 150 Tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
How Idrofos 150 Tablet works:
Idrofos 150 mg tablets contain a bisphosphonate, a medication that inhibits osteoclast function. By reducing bone breakdown, this treatment fortifies bone structure and decreases fracture vulnerability.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Idrofos 150 Tablet necessitates caution. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Idrofos 150 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Idrofos 150 Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Idrofos 150 Tablet.
KidneySAFE IF PRESCRIBED
Idrofos 150 Tablet presents no safety concerns for patients with kidney disease and requires no dosage modification. Nevertheless, its administration is inadvisable for individuals experiencing severe renal dysfunction.
LiverSAFE IF PRESCRIBED
Use of Idrofos 150 Tablet in patients with liver disease is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Idrofos 150 Tablet :
Omit any missed Idrofos 150 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Idrofos 150 Tablet
| Label | Value |
|---|---|
| Chemical Type | Bisphosphonate Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Actions | Bisphosphonates: Bone Resorption Inhibitors |





